Release Date: 21/08/17 09:55 Summary: In Orbit Testing Completed Successfully Price Sensitive: Yes Download Document 188.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%